EUVIMEDEUVIMED entdecken
Crossref

Liraglutide attenuates hepatocyte ferroptosis in an in vitro model of metabolic dysfunction-associated steatotic liver disease

J Bai, Y Xiao, P Lou, J Zhang, Y Liu, Y Zhou

Physiological Research · 31.10.2026 · 909

DOI: 10.33549/physiolres.935793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Physiological Research, online erschienen am 31.10.2026. Verfasst von J Bai und 5 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study examined the potential of liraglutide to attenuate ferroptosis in an in vitro model of metabolic dysfunction-associated steatotic liver disease (MASLD). HepG2 cells were allocated into three groups: control (Con), free fatty acid (FFA)-treated, and FFA with liraglutide treatment (FFA+LI). After 48 h of treatment, intracellular triglyceride (TG), glutathione (GSH), malondialdehyde (MDA), and iron levels were quantified using commercially available kits. Superoxide dismutase (SOD) activity was also measured. Lipid accumulation was visualized via Oil Red O staining. Expression of ferroptosis-associated genes was assessed through quantitative RT-PCR and western blotting. FFA treatment induced significant lipid accumulation, elevated TG, MDA, and iron levels, and reduced SOD activity and GSH levels compared to the Con group (all p

Zitieren

APA

Bai, J., Xiao, Y., Lou, P., Zhang, J., Liu, Y., & Zhou, Y. (2026). Liraglutide attenuates hepatocyte ferroptosis in an in vitro model of metabolic dysfunction-associated steatotic liver disease. Physiological Research, 909. https://doi.org/10.33549/physiolres.935793

Vancouver

Bai J, Xiao Y, Lou P, Zhang J, Liu Y, Zhou Y. Liraglutide attenuates hepatocyte ferroptosis in an in vitro model of metabolic dysfunction-associated steatotic liver disease. Physiological Research. 2026:909. doi:10.33549/physiolres.935793

BibTeX
@article{Bai2026,
  author = {Bai, J and Xiao, Y and Lou, P and Zhang, J and Liu, Y and Zhou, Y},
  title = {Liraglutide attenuates hepatocyte ferroptosis in an in vitro model of metabolic dysfunction-associated steatotic liver disease},
  journal = {Physiological Research},
  year = {2026},
  pages = {909},
  doi = {10.33549/physiolres.935793}
}
Kostenlos starten →